43 articles
Returning guest, Derek Wallace, MBBS, Vice President and Global Dengue Program Head at Takeda, discusses the approval of the company’s dengue vaccine,...
Gregg Sylvester, Chief Health Officer at CSL Seqirus, one of the world’s largest influenza providers, discusses the CDC’s Advisory Committee on Imm...
Pascale Leroueil, Vice President of Healthcare at the William Davidson Institute at the University of Michigan discusses a recent study where she and co...
The CDC’s Advisory Committee on Immunization Practices (ACIP) is currently reviewing enhanced influenza vaccines (EIV), which are shots recommended to...
Jeff Skolnik, Senior Vice President of Clinical Development at INOVIO Pharmaceuticals, discusses the current research and development of a DNA vaccine f...
Elizabeth Profita, MD, a pediatric cardiologist at Stanford Children's Health discusses how to weigh the risks and benefits of COVID-19 vaccination in d...
Dorry Segev, Professor of Surgery and Epidemiology and Associate Vice Chair of Surgery at Johns Hopkins University discusses the impact of COVID on the ...
Gregg Sylvester, MD, Chief Medical Officer at Seqirus, one of the world’s largest influenza vaccine providers discusses some new real-world evidenc...
Jessica Solis-McCarthy, MD, FACEP, emergency medicine physician at UT Health San Antonio and University Hospital and spokesperson for the American Colle...
Joaquin Mould-Quevedo, Global Pricing and Health Economics Director at Seqirus, a global leader in seasonal influenza prevention and pandemic influenza ...